Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 5Colorectal Neoplasms 4Barrett Esophagus 3Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Urogenital Neoplasms 1Upper Tract Urothelial Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Primary Effusion 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Lung Neoplasms 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Fistula 1Esophageal Squamous Cell Carcinoma 1Disease 1Colitis 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Non-Small-Cell Lung 1Bacteremia 1Adenoma 1Adenocarcinoma 1

Interventions

Oxaliplatin 27Fluorouracil 23Leucovorin 22Cetuximab 22Bevacizumab 21Nivolumab 16Capecitabine 16Irinotecan 15pembrolizumab 11Magnetic Resonance Spectroscopy 11Specimen Handling 10encorafenib 8Folfox protocol 7trifluridine tipiracil drug combination 6Ipilimumab 6Exercise 6fludarabine 5cemiplimab 5Trastuzumab 5Gemcitabine 5Cyclophosphamide 5Cisplatin 5Blood Specimen Collection 5Biopsy 5regorafenib 4pertuzumab 4adagrasib 4Trifluridine 4Pemetrexed 4Immune Checkpoint Inhibitors 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Endoscopy × 1 year × Clear all
NCT07405476 2026-04-17

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Emory University

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02738359 2026-02-27

FAMCAP

Hôpital Edouard Herriot

Completed
84 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡